First Citizens Bank & Trust’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.32M Sell
73,799
-1,072
-1% -$141K 0.14% 95
2026
Q1
$10.4M Buy
74,871
+820
+1% +$115K 0.22% 78
2025
Q4
$9.09M Buy
74,051
+1,580
+2% +$192K 0.19% 91
2025
Q3
$8.04M Buy
72,471
+61,959
+589% +$7.04M 0.17% 96
2025
Q2
$1.17M Sell
10,512
-4,116
-28% -$438K 0.02% 261
2025
Q1
$1.64M Sell
14,628
-840
-5% -$86.7K 0.04% 197
2024
Q4
$1.43M Buy
15,468
+193
+1% +$17.4K 0.03% 211
2024
Q3
$1.28M Buy
15,275
+253
+2% +$19.3K 0.03% 222
2024
Q2
$1.03M Buy
15,022
+46
+0.3% +$3.07K 0.02% 240
2024
Q1
$1.1M Buy
+14,976
New +$1.15M 0.02% 237
2023
Q4
Sell
-5,458
Closed -$409K 367
2023
Q3
$409K Buy
5,458
+329
+6% +$25.3K 0.01% 262
2023
Q2
$395K Sell
5,129
-493
-9% -$39.3K 0.01% 271
2023
Q1
$466K Sell
5,622
-437
-7% -$36.2K 0.01% 234
2022
Q4
$520K Buy
6,059
+294
+5% +$23.3K 0.02% 212
2022
Q3
$356K Buy
5,765
+28
+0.5% +$1.77K 0.01% 243
2022
Q2
$355K Buy
5,737
+1,935
+51% +$120K 0.01% 261
2022
Q1
$226K Sell
3,802
-14
-0.4% -$895 0.01% 381
2021
Q4
$277K Sell
3,816
-375
-9% -$25.8K 0.01% 322
2021
Q3
$293K Buy
4,191
+95
+2% +$6.67K 0.01% 294
2021
Q2
$282K Sell
4,096
-50
-1% -$3.34K 0.01% 312
2021
Q1
$268K Buy
4,146
+32
+0.8% +$2.06K 0.01% 326
2020
Q4
$240K Sell
4,114
-16,508
-80% -$996K 0.01% 324
2020
Q3
$1.3M Sell
20,622
-14,769
-42% -$1.02M 0.09% 164
2020
Q2
$2.72M Buy
35,391
+10,874
+44% +$833K 0.23% 97
2020
Q1
$1.83M Buy
24,517
+19,637
+402% +$1.36M 0.22% 102
2019
Q4
$317K Sell
4,880
-239
-5% -$15.6K 0.03% 249
2019
Q3
$325K Buy
5,119
+220
+4% +$14.4K 0.04% 252
2019
Q2
$331K Sell
4,899
-74
-1% -$4.87K 0.04% 346
2019
Q1
$323K Sell
4,973
-25
-0.5% -$1.66K 0.04% 348
2018
Q4
$313K Sell
4,998
-164
-3% -$11.5K 0.04% 277
2018
Q3
$398K Sell
5,162
-101
-2% -$7.63K 0.04% 260
2018
Q2
$373K Buy
5,263
+38
+0.7% +$2.68K 0.05% 272
2018
Q1
$394K Buy
5,225
+176
+3% +$14K 0.05% 248
2017
Q4
$362K Sell
5,049
-86
-2% -$6.53K 0.05% 252
2017
Q3
$416K Sell
5,135
-6,966
-58% -$533K 0.05% 244
2017
Q2
$857K Sell
12,101
-4,311
-26% -$287K 0.11% 179
2017
Q1
$1.11M Sell
16,412
-57,518
-78% -$4.04M 0.14% 158
2016
Q4
$5.29M Sell
73,930
-31,330
-30% -$2.33M 0.58% 52
2016
Q3
$8.33M Sell
105,260
-11,351
-10% -$922K 0.76% 38
2016
Q2
$9.73M Sell
116,611
-24,917
-18% -$2.21M 0.87% 32
2016
Q1
$13M Sell
141,528
-5,888
-4% -$531K 1.09% 24
2015
Q4
$14.9M Sell
147,416
-18,300
-11% -$1.9M 1.09% 23
2015
Q3
$16.3M Buy
165,716
+18,816
+13% +$2.09M 1.21% 18
2015
Q2
$17.2M Buy
146,900
+51,872
+55% +$5.67M 1.19% 17
2015
Q1
$9.32M Buy
95,028
+1,395
+1% +$142K 0.64% 50
2014
Q4
$8.83M Buy
93,633
+61,772
+194% +$6.39M 0.68% 54
2014
Q3
$3.39M Sell
31,861
-104
-0.3% -$10.2K 0.28% 101
2014
Q2
$2.65M Buy
31,965
+17,349
+119% +$1.35M 0.23% 101
2014
Q1
$1.04M Buy
14,616
+11,774
+414% +$923K 0.09% 145
2013
Q4
$213K Sell
2,842
-141,248
-98% -$9.84M 0.02% 305
2013
Q3
$9.06M Buy
144,090
+2,553
+2% +$153K 0.35% 75
2013
Q2
$7.26M Buy
+141,537
New +$7.38M 0.3% 90

Other funds holding GILD

First Citizens Bank & Trust's GILD Position: Q2 2026 in Review

First Citizens Bank & Trust reduced its Gilead Sciences (GILD) stake by 1.4% in Q2 2026, selling an estimated $141K and leaving 73,799 shares worth $9.32M. The position accounts for 0.14% of the portfolio, ranked #95.

First Citizens Bank & Trust first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.2M in Q2 2015. 396 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • First Citizens Bank & Trust held 73,799 shares of Gilead Sciences worth $9.32M as of Q2 2026.
  • First Citizens Bank & Trust sold 1,072 Gilead Sciences shares in Q2 2026, an estimated $141K.
  • Gilead Sciences made up 0.14% of First Citizens Bank & Trust's portfolio in Q2 2026, its #95 holding.
  • First Citizens Bank & Trust first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • First Citizens Bank & Trust's Gilead Sciences position peaked at $17.2M in Q2 2015.
  • 396 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on First Citizens Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.